UBE2Q2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.538580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.864100E-02
Normal-vs-Stage2
1.625580E-01
Normal-vs-Stage3
1.670950E-01
Normal-vs-Stage4
5.728400E-01
Stage1-vs-Stage2
8.129800E-01
Stage1-vs-Stage3
8.617200E-01
Stage1-vs-Stage4
1.663590E-01
Stage2-vs-Stage3
7.234200E-01
Stage2-vs-Stage4
3.188600E-01
Stage3-vs-Stage4
2.657600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.504400E-01
Normal-vs-AfricanAmerican
5.346400E-01
Normal-vs-Asian
9.278200E-02
Caucasian-vs-AfricanAmerican
2.490600E-01
Caucasian-vs-Asian
3.793600E-01
AfricanAmerican-vs-Asian
1.303380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.886600E-01
Normal-vs-Female
1.210800E-01
Male-vs-Female
7.694200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.760180E-01
Normal-vs-Age(41-60Yrs)
3.253800E-01
Normal-vs-Age(61-80Yrs)
1.195150E-01
Normal-vs-Age(81-100Yrs)
6.363800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.005800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.075800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.155400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.770300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.082180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.174190E-01
Normal-vs-Daily Drinker
1.333910E-02
Normal-vs-Weekly Drinker
3.330200E-01
Normal-vs-Occasional Drinker
1.531840E-01
Normal-vs-Social Drinker
3.308800E-01
Non Drinker-vs-Daily Drinker
2.259600E-01
Non Drinker-vs-Weekly Drinker
2.693200E-01
Non Drinker-vs-Occasional Drinker
6.700200E-01
Non Drinker-vs-Social Drinker
6.725200E-01
Daily Drinker-vs-Weekly Drinker
2.740000E-02
Daily Drinker-vs-Occasional Drinker
1.093650E-01
Daily Drinker-vs-Social Drinker
2.358200E-01
Weekly Drinker-vs-Occasional Drinker
4.880000E-01
Weekly Drinker-vs-Social Drinker
6.359600E-01
Occasional Drinker-vs-Social Drinker
9.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.478000E-01
Normal-vs-Grade 2
8.285000E-01
Normal-vs-Grade 3
8.861600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.239700E-02
Grade 1-vs-Grade 3
4.256800E-01
Grade 1-vs-Grade 4
9.478000E-01
Grade 2-vs-Grade 3
2.554800E-01
Grade 2-vs-Grade 4
8.285000E-01
Grade 3-vs-Grade 4
8.861600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.010430E-01
Normal-vs-NonDiabetic
1.304840E-01
Diabetic-vs-NonDiabetic
4.960400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.544970E-01
Normal-vs-NoPancreatitis
1.309810E-01
Pancreatitis-vs-NoPancreatitis
9.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.244230E-01
Normal-vs-N1
1.869200E-01
N0-vs-N1
3.641200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.242800E-01
Normal-vs-TP53-NonMutant
1.273850E-01
TP53-Mutant-vs-TP53-NonMutant
2.500800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
